Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Cardiovascular Diseases

Increasing Incidence, Influx of Companies add t...

Myocardial infarction is an irreversible death of heart muscles. It is pathologically referred to as myocardial cell death due to a prolonged lack of oxygen supply (ischemia). The condition is acco...

Oct 04, 2021

pharma-news-updates-for-roche-mayo-clinic-owlstone-transmedics-google
Roche inks $3B deal; Owlstone raises $58M; FDA approves OCS heart system; Google, Mayo Clinic build brain-mapping AI algorithm

Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 Billion A collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will collaborate with Adaptimmune for developing and commercializing allogeneic T-cell therapies to treat multiple cancer indic...

Find More
medtech-news-and-updates-for-abiomed-helius-smart-meter-bd-veritor-xact
Abiomed’s Impella ECP; Helius’s PoNS Device; Smart Meter’s iGlucose BGM; XACT’s CT-Guided Percutaneous Procedures; BD’s Veritor At-Home COVID-19 Test; Delfi’s Liquid Biopsy

FDA awards Breakthrough Device Designation to Impella ECP  On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) for its Impella ECP expandable percutaneous heart pump, the world’s smallest heart pump and the first to be compatible wit...

Find More
venous-thromboembolism-market-size-share-trends-companies-cagr-growth-therapy-treatment-therapeutics
Venous Thromboembolism Market Growth Quadrant to Balloon Up

Venous thromboembolism (VTE) is a condition that is characterized by the development of blood clots in the veins. The condition includes Deep vein thrombosis (DVT) which occurs when a blood clot forms in a deep vein of the lower legs or pelvic area. However, in some cases, the blood clots from pelvic areas may brea...

Find More

More Views & Analysis

medtech-news-updates-for-boston-scientific-kestra-zoll-fujifilm-cytosorbents-lunit
Boston Scientific’s EkoSonic; FDA clearance for EXALT; Kestra Medical’s ASSURE; ZOLL Next-Generation remedē system; CytoSorbents’ DrugSorb-ATR; Fujifilm-Lunit collaboration

Boston Scientific starts recruitment for randomized controlled trials for the EkoSonic™ Endovascular System On August 04, 2021, Boston Scientific Corporation started the enrolment in the HI-PEITHO clinical trial, which is a collaborative research study with the Pulmonary Embolism Response Team (PERT) Cons...

Find More

advances-in-diabetes-care-treatment-devices-management-approaches
New Approaches and Evolutions to Reshape the Diabetes Management and Care

As per the WHO, “the number of people affected with Diabetes has grown significantly from 108 million in 1980 to 422 million in 2014. A rising trend in prevalence is observed in low- and middle-income countries as compared to high-income countries”. Additionally, Diabetes is a significant cause of the number of dea...

Find More

medtech-news-updates-for-nevro-nuvasive-medtronic-boston-angelmed-memed
Nevro’s Spinal Cord Stimulation; Boston’s PINNACLE FLX; NuVasive’s Modulus ALIF; J&J’s VERITAS Vision System; Medtronic’s DCB Catheter; AngelMed’s Heart Attack Warning System

Nevro Received FDA Approval of its 10 kHz High-Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy On July 19, 2021, Nevro Corp. received approval for its Senza System, Nevro's unique 10 kHz stimulation, to treat chronic pain associated with Painful...

Find More

cardiac-monitoring-devices-market
With advancements in Innovative Technology, Cardiac Monitoring Devices Market is Booming Significantly

Cardiac monitoring devices are important for cardiovascular care, to assess the occurrence and seriousness of cardiac failure and to evaluate the success of therapies such as medications, procedures, and device implants. Cardiovascular diseases (CVDs) are a global cause of death, which can be prevented. In most cas...

Find More

latest-medtech-updates-and-approval-of-devices
MedTech Market Industry: Approval of Devices, Therapy Address Market Needs | Clinical Outcomes Create New Value

LivaNova Secures FDA Approval for Clinical Study to Assess the aura6000 System for Obstructive Sleep Apnea Treatment   On June 15, 2021, LivaNova PLC received approval from the US Food and Drug Administration (FDA) to continue with its investigational device exemption (IDE) clinical study, “Treating Ob...

Find More

Intellia's Quest with CRISPR; Innovent, Synaffix ADC Tech Deal; Lilly's Diabetes Blockbuster Tirzepatide; Polyphor’s Bleak Future
Intellia’s Quest with CRISPR; Innovent, Synaffix ADC Tech Deal; Lilly’s Diabetes Blockbuster Tirzepatide; Polyphor’s Bleak Future

A New Dawn for CRISPR, Intellia Edits Cells Inside the Body Intellia Therapeutics, along with its partner Regeneron Pharmaceuticals, recently announced its successful attempt in editing the cells inside the body leveraging the CRISPR technique. The world’s first-ever trial that has their DNA edited through an in...

Find More

Healthcare Performance Improvement provides proven methods for sustaining and building a culture of .....

Find More

The convergence of technologies and the increasing integration of medical devices to computer networ.....

Find More

Cancer immunotherapy which is known to reactivate weakened immune cells of cancer patients, has yiel.....

Find More

A rare neurological disorder characterized by progressive weakness and impaired sensory function in .....

Find More

Systemic Lupus Erythematosus (SLE) is an autoimmune disease where the immune system of the body mist.....

Find More

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Find More